AEON Biopharma Inc Share Price Today: Live Updates & Key Insights

AEON Biopharma Inc share price today is $1.07, up -5.31%. The stock opened at $1.12 against the previous close of $1.13, with an intraday high of $1.14 and low of $1.07.

AEON Biopharma Inc Share Price Chart

AEON Biopharma Inc

us-stock
To Invest in {{usstockname}}
us-stock

AEON Biopharma Inc Share Price Performance

$1.07 -0.0531(-5.31%) AEON at 23 Mar 2026 11:54 AM Biotechnology
Lowest Today 1.07
Highest Today 1.14
Today’s Open 1.12
Prev. Close 1.13
52 Week High 1.45
52 Week Low 0.38
Day’s Range: Low 1.07 High 1.14
52-Week Range: Low 0.38 High 1.45
1 day return -
1 Week return -3.5
1 month return -12.69
3 month return +5.76
6 month return +43.97
1 year return +54.92
3 year return -89.18
5 year return -88.86
10 year return -

AEON Biopharma Inc Institutional Holdings

AEON Biopharma Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

AEON Biopharma Inc Fundamentals

Market Cap 10.95 M

PB Ratio 0.0

PE Ratio 0.0

Enterprise Value 39.40 M

Total Assets 3.14 M

Volume 64653

AEON Biopharma Inc Company Financials

Annual Revenue FY22:0 0.0M, FY21:0 0.0M, FY20:2518000 2.5M, FY19:3357000 3.4M

Annual Profit FY22:null 0.0M, FY21:null 0.0M, FY20:2518000 2.5M, FY19:3356000 3.4M

Annual Net worth FY22:-52556000 -52.6M, FY21:-55637000 -55.6M, FY20:-32913000 -32.9M, FY19:172920000 172.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-4538000 -4.5M, Q2/2025:-6642000 -6.6M, Q1/2025:9095000 9.1M, Q3/2024:-6171000 -6.2M, Q2/2024:164112000 164.1M

About AEON Biopharma Inc & investment objective

Company Information AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.

Organisation Biotechnology

Employees 5

Industry Biotechnology

CEO Mr. Robert Bancroft

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

AEON Biopharma Inc FAQs

What is the share price of AEON Biopharma Inc today?

The current share price of AEON Biopharma Inc is $1.07.

Can I buy AEON Biopharma Inc shares in India?

Yes, Indian investors can buy AEON Biopharma Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy AEON Biopharma Inc shares in India?

You can easily invest in AEON Biopharma Inc shares from India by:

Can I buy fractional shares of AEON Biopharma Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of AEON Biopharma Inc?

AEON Biopharma Inc has a market cap of $10.95 M.

In which sector does AEON Biopharma Inc belong?

AEON Biopharma Inc operates in the Biotechnology sector.

What documents are required to invest in AEON Biopharma Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of AEON Biopharma Inc?

The PE ratio of AEON Biopharma Inc is N/A and the PB ratio is N/A.